Publication | Closed Access
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
103
Citations
27
References
2017
Year
InflammationMedical MicrobiologyAntimicrobial SusceptibilityAntibioticsMedicineCystic Fibrosis PatientsPseudomonas AeruginosaNovel Anti-inflammatoryMicrobiologyInfection ControlAntimicrobial ChemotherapyAntimicrobial CompoundBacterial PathogensClinical MicrobiologyAntimicrobial Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1